Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 14/20 | 0.51 |
| ▸ | ITGB3 | P05106 | 13/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 13/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7652751 | 0.91 | ITGB3 (0.61) | ITGAVITGB3ITGA2B | |
| SCHEMBL383160 | 0.80 | ITGAV (0.58) | ITGAVITGB3ITGA2B | |
| SCHEMBL382660 | 0.79 | MAPT (0.42) | ITGAVITGB3ITGA2BLMNAMAPT | |
| SCHEMBL383584 | 0.78 | ITGB3 (0.77) | ITGAVITGB3ITGA2B | |
| SCHEMBL7652767 | 0.78 | ITGB3 (0.44) | ITGAVITGB3ITGA2BLMNAMAPT | |
| SCHEMBL383468 | 0.77 | ITGB3 (0.51) | ITGAVITGB3ITGA2B | |
| SCHEMBL7652758 | 0.77 | GFER (0.43) | ITGAVITGB3ITGA2BLMNAMAPT | |
| SCHEMBL382657 | 0.77 | ALDH1A1 (0.42) | ITGAVITGB3ITGA2BLMNAMAPT | |
| SCHEMBL382658 | 0.76 | MAPT (0.40) | ITGAVITGB3ITGA2BLMNAMAPT | |
| SCHEMBL382572 | 0.76 | ITGAV (0.53) | ITGAVITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1074543-B1 | AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS | MEIJI SEIKA PHARMA CO LTD (JP) | 2012-01-25 | — | — | EP | disclosed |